FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 337:636 August 28, 1997 Number 9 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Appel, L. J. PubMed Citation

To the Editor: The appetite-suppressant drugs fenfluramine, dexfenfluramine (the purified d isomer of fenfluramine), and phentermine have each been associated with an increased risk of pulmonary hypertension when used alone.^1,2,3 In this issue of the Journal, an unusual form of valvular heart disease is reported to be associated with use of the combination drug fenfluramine–phentermine,⁴ but whether valvular disease is also associated with use of the single agent dexfenfluramine is unknown. We wish to report a case of unusual valvular heart disease involving primarily the mitral valve in a young woman taking dexfenfluramine.

A 32-year-old woman was referred for evaluation . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Hoey, J. (2001). The sodium-restricted DASH diet lowers blood pressure. CMAJ 164: 1613-1613 [Full Text]  
• Gardin, J. M., Schumacher, D., Constantine, G., Davis, K. D., Leung, C., Reid, C. L. (2000). Valvular Abnormalities and Cardiovascular Status Following Exposure to Dexfenfluramine or Phentermine/Fenfluramine. JAMA 283: 1703-1709 [Abstract] [Full Text]  
• Miller, G. D., DiRienzo, D. D., Reusser, M. E., McCarron, D. A. (2000). Benefits of Dairy Product Consumption on Blood Pressure in Humans: A Summary of the Biomedical Literature. J. Am. Coll. Nutr. 19: 147S-164 [Abstract] [Full Text]  
• Williamson, D. F., Yanovski, S. Z., Myers, M. D., Moye, L. A., Annegers, J. F., Paoletti, C. F., Shapiro, S., Khan, M. A., St. Peter, J. V., Herzog, C. A., Jick, H., Weissman, N. J., Gottdiener, J. S., Gwynne, J. T., Devereux, R. B., Cannistra, L. B., Cannistra, A. J. (1999). Appetite-Suppressant Drugs and Valvular Heart Disease. NEJM 340: 476-480 [Full Text]  
• Hu, S., Wang, S., Gibson, J., Gilbertson, T. A. (1998). Inhibition of Delayed Rectifier K+ Channels by Dexfenfluramine (Redux). J. Pharmacol. Exp. Ther. 287: 480-486 [Abstract] [Full Text]  
• Weissman, N. J., Tighe, J. F., Gottdiener, J. S., Gwynne, J. T., The Sustained-Release Dexfenfluramine Study Group, (1998). An Assessment of Heart-Valve Abnormalities in Obese Patients Taking Dexfenfluramine, Sustained-Release Dexfenfluramine, or Placebo. NEJM 339: 725-732 [Abstract] [Full Text]  
• Cannistra, L. B., Cannistra, A. J. (1998). Regression of Multivalvular Regurgitation after the Cessation of Fenfluramine and Phentermine Treatment. NEJM 339: 771-771 [Full Text]  
• Thompson, P. D., Kurz, X., Van Ermen, A., Rasmussen, S., Corya, B. C., Glassman, R. D., Redmon, B., Raatz, S., Bantle, J. P., Wolff, F. W., Spitzer, W. O., Marshall, E. M., Connolly, H. M., McGoon, M. D., Curfman, G. D. (1997). Valvular Heart Disease Associated with Fenfluramine-Phentermine. NEJM 337: 1772-1776 [Full Text]  
• Marinella, M. A., Berrettoni, B. A. (1997). Digital Necrosis Associated with Dexfenfluramine. NEJM 337: 1776-1777 [Full Text]  
• (1997). MORE ON DIET PILLS AND VALVULAR DISEASE. JWatch General 1997: 1-1 [Full Text]  
• Curfman, G. D. (1997). Diet Pills Redux. NEJM 337: 629-630 [Full Text]